|
|
Starpharma Holdings Limited - Comparative Business Analysis Snapshot
Business Description
Starpharma Holdings Limited. The Group's principal activity is discovering, developing and commercialising dendrimer products for pharmaceutical, life sciences and other applications. The Group's operation is directed towards the development of precisely defined nano-scale materials for use in pharmaceutical applications with a particular focus on the development of topical vaginal microbicides for the prevention of Human immunodeficiency virus and other sexually transmitted diseases. The Group's main product brands is VivaGel. It operates in Australia and United States.
Competitor Analysis
This analysis compares Starpharma Holdings Limited with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
